Randomized, prospective, comparative trial of ex-press glaucoma filtration device versus trabeculectomy (XVT Study)

Peter A. Netland, Steven R. Sarkisian, Marlene R. Moster, Iqbal Ike K. Ahmed, Garry Condon, Sarwat Salim, Mark B. Sherwood, Carla J. Siegfried

Research output: Contribution to journalArticle

80 Scopus citations

Abstract

Purpose To compare the clinical outcomes of the EX-PRESS glaucoma filtration device placed under a partial-thickness scleral flap with trabeculectomy. Design Randomized, prospective, multicenter trial. Methods A total of 120 eyes in 120 subjects were analyzed, including 59 eyes treated with EX-PRESS and 61 eyes treated with trabeculectomy. Both the EX-PRESS and the trabeculectomy groups were treated intraoperatively with mitomycin C and followed postoperatively for 2 years. Surgical success was defined as 5 mm Hg ≤ intraocular pressure ≤ 18 mm Hg, with or without medications, without further glaucoma surgery. Results Mean intraocular pressure was significantly reduced compared with baseline in both groups (P < 0.001). Average intraocular pressure and number of medications were similar in both groups during follow-up, with mean intraocular pressure at 2 years after surgery of 14.7 ± 4.6 mm Hg and 14.6 ± 7.1 mm Hg in the EX-PRESS and trabeculectomy groups, respectively (P = 0.927). At 2 years after surgery, the success rate was 83% and 79% in the EX-PRESS and trabeculectomy groups, respectively (P = 0.563). Although visual acuity (logMAR) was significantly decreased on day 1 in both groups, the vision was not significantly different compared with baseline at 1 month after EX-PRESS implant (P = 0.285) and 3 months after trabeculectomy (P = 0.255). The variance of early postoperative intraocular pressure values was similar between groups on the first postoperative day but higher after trabeculectomy compared with EX-PRESS implant on day 7 (P = 0.003). The total number of postoperative complications was higher after trabeculectomy than after EX-PRESS implantation (P = 0.013). Conclusions Mean intraocular pressures, medication use, and surgical success were similar at 2 years after treatment with the EX-PRESS device and trabeculectomy. Vision recovery between groups was also similar throughout the study, although return to baseline vision was more rapid in the EX-PRESS group. Intraocular pressure variation was lower during the early postoperative period, and postoperative complications were less common after EX-PRESS implantation compared with trabeculectomy.

Original languageEnglish
Pages (from-to)433-440.e3
JournalAmerican journal of ophthalmology
Volume157
Issue number2
DOIs
StatePublished - Feb 2014

Fingerprint Dive into the research topics of 'Randomized, prospective, comparative trial of ex-press glaucoma filtration device versus trabeculectomy (XVT Study)'. Together they form a unique fingerprint.

  • Cite this